FDA urges lower dosages for anemia drugs - chicagotribune.com
Links shared publicly online about this topic.
- 195total visits
FDA urges lower dosages for anemia drugs - chicagotribune.com
View full resource at chicagotribune.com
Tags: Anemia, Anemia Medication, Drug, Healthy Living, FDA, Johnson & Johnson, Amgen
Most Recently Shared on June 24, 2011 at 9:09 pm By:
FDA urges lower dosages for Amgen, J&J anemia drugs: U.S. health regulators on Friday urged more conservative d... http://trib.in/k8ciuH
FDA urges low dosing on anemia meds - FiercePharma
fiercepharma.com — “In a decision that contradicts a recent choice by Medicare officials to continue reimbursing for the drugs at current dosage levels, the FDA is advising cutbacks on dosage for anemia drugs sold by Read more...” View full resource at fiercepharma.com
Most Recently Shared on June 27, 2011 at 2:47 pm By:
FDA urges low dosing on anemia meds. http://bit.ly/iNa1PQ
Lower Dosages For Anemia Drugs For Patients With Chronic Kidney Disease, FDA
medicalnewstoday.com — “In a move to address the risk of cardiovascular events linked to Erythropoiesis-Stimulating Agents (ESAs) used in anemia treatment for patients with chronic kidney disease, the FDA (Food and Drug” View full resource at medicalnewstoday.com
Most Recently Shared on June 24, 2011 at 8:05 pm By:
Lower Dosages For Anemia Drugs For Patients With Chronic Kidney Disease, FDA http://mnt.to/3XFg #blood #hematology
Medical News: FDA Urges Tailored Dosing for Anemia Drugs - in Nephrology, Anemia from MedPage Today
medpagetoday.com — “To treat anemia in chronic kidney disease patients who are not on dialysis, physicians should consider starting erythropoiesis-stimulating agents (ESAs) only when hemoglobin levels drop below 10 g/dL,” View full resource at medpagetoday.com
Most Recently Shared on June 24, 2011 at 7:45 pm By:
Paul Cacciatore Patient Advocate
FDA urges lower hemoglobin targets 4 anemia drugs (Epogen, Procrit & Aranesp), but warning does not apply 2 cancer pts. http://dld.bz/ae4VA
FDA Urges Lower Hb Targets for Anemia Drugs - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- To treat anemia in chronic kidney disease patients who are not on dialysis, physicians should consider starting erythropoiesis-stimulating agents (ESAs) only when hemoglobin levels drop below 10 g/dL, the FDA said on Friday.” View full resource at qualitypointtech.net
Most Recently Shared on June 24, 2011 at 6:00 pm By:
FDA Urges Lower Hb Targets for Anemia Drugs: (MedPage Today) -- To treat anemia in chronic kidney disease patients... http://bit.ly/lTIP8c
Medical News: FDA Urges Tailored Dosing for Anemia Drugs - in Nephrology, Anemia from MedPage Today
medpagetoday.com — “To treat anemia in chronic kidney disease patients who are not on dialysis, physicians should consider starting erythropoiesis-stimulating agents (ESAs) only when hemoglobin levels drop below 10 g/dL,” View full resource at medpagetoday.com
Most Recently Shared on June 24, 2011 at 5:44 pm By:
Physician Assistants Health News Feed
FDA Urges Lower Hb Targets for Anemia Drugs: http://bit.ly/kOtIMv "more conservative dosing guideline" for erythropoiesis-stimulating agents
Advertisement
